Revolutionizing Cancer Treatment: Key Bispecific Antibody Approvals

Panelists discuss how recent FDA approvals for bispecific antibodies in oncology, particularly for hematologic malignancies like multiple myeloma and lymphomas, represent significant treatment advances, while highlighting expanding applications in solid tumors, autoimmune disorders, and infectious diseases as promising growth areas for this therapeutic modality.

EP: 1.Expanding Horizons: The Present and Future of Bispecific Antibodies Across Oncology

Now Viewing

EP: 2.Revolutionizing Cancer Treatment: Key Bispecific Antibody Approvals

Video content above is prompted by the following:

• What are the most significant recent approvals for bispecific antibodies in oncology?
• What therapeutic areas are seeing growth in bispecific antibody applications?

Related Videos

Related Content

Advertisement

March 3rd 2025

Health Equity & Access Weekly Roundup: March 3, 2025

Giuliana Grossi

The Center on Health Equity & Access delves into the latest research, policy shifts, and expert viewpoints on advancing equity and improving access to care.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

February 28th 2025

Survey Explores Needs of Patients With DMD, BMD Transitioning to Adulthood

Rose McNulty

Activities of daily life, education, and employment were areas of difficulty in the transition to adulthood for patients with Duchenne muscular dystrophy (DMD) or Becker muscular dystrophy (BMD), but those who had more siblings reported being more ready to transition to adult life.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

February 26th 2025

RA-Specific Physical Activity Resources Provide Guidance but Need Improvement

Brooke McCormick

An extensive library of physical activity resources will better support the different needs, capabilities, and considerations of patients with rheumatoid arthritis (RA), according to the researchers.

February 26th 2025

Disease Burden From Myasthenia Gravis Consistently High

Maggie L. Shaw

Myasthenia gravis is becoming increasingly common around the world, with a resulting disease burden beset by high health care resource utilization, decreased quality of life, and worsened mental health.

Related Content

Advertisement

March 3rd 2025

Health Equity & Access Weekly Roundup: March 3, 2025

Giuliana Grossi

The Center on Health Equity & Access delves into the latest research, policy shifts, and expert viewpoints on advancing equity and improving access to care.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

February 28th 2025

Survey Explores Needs of Patients With DMD, BMD Transitioning to Adulthood

Rose McNulty

Activities of daily life, education, and employment were areas of difficulty in the transition to adulthood for patients with Duchenne muscular dystrophy (DMD) or Becker muscular dystrophy (BMD), but those who had more siblings reported being more ready to transition to adult life.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

February 26th 2025

RA-Specific Physical Activity Resources Provide Guidance but Need Improvement

Brooke McCormick

An extensive library of physical activity resources will better support the different needs, capabilities, and considerations of patients with rheumatoid arthritis (RA), according to the researchers.

February 26th 2025

Disease Burden From Myasthenia Gravis Consistently High

Maggie L. Shaw

Myasthenia gravis is becoming increasingly common around the world, with a resulting disease burden beset by high health care resource utilization, decreased quality of life, and worsened mental health.